Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular and Clinical Oncology|December 21, 2023
Lenalidomide use in multiple myeloma (Review)Chao-Wei Zhang, Ya-Nan Wang, Xue-Ling Ge
Technology in Cancer Research & Treatment|March 25, 2025
The Progress of Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Myeloma (Review)Ya-Nan Wang, Chao-Wei Zhang, Yu-Xuan Gao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 2, 2011
[Expression and clinical significances of hedgehog signaling pathway in non-Hodgkin's lymphoma]Xi-Yuan Zhang, Xiao-Qian Liu, Xue-Ling Ge, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 27, 2010
[Clinical significance of Livin expression in non-Hodgkin's lymphoma]Jun-Ming Gao, Xin Wang, Xiao-Qian Liu, et al.
Leukemia & Lymphoma|May 21, 2013
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltrationXiao-Qian Liu, Kang Lu, Li-Li Feng, et al.
International Journal of Clinical and Experimental Medicine|September 19, 2014
Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphomaPei-Pei Li, Li-Li Feng, Na Chen, et al.
Medical Oncology (Northwood, London, England)|January 11, 2015
Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathwayPei-Pei Li, Li-Li Feng, Na Chen, et al.
International Journal of Clinical and Experimental Pathology|May 13, 2014
Metadherin contribute to BCR signaling in chronic lymphocytic leukemiaPei-Pei Li, Qing-Min Yao, Hui Zhou, et al.
Biochemical and Biophysical Research Communications|June 28, 2015
The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cellsKang Lu, Na Chen, Xiang-xiang Zhou, et al.
Pageof 1